SEC Form 4 · accession 0001104659-18-020100

Voyager Therapeutics, Inc. · VYGR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr. V.P. & CFO, Corp. Dev.

Period of report

Mar 22, 2018

Accepted (ET)

Mar 26, 2018 · 4:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001640266

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 22, 2018	M	19,900	$11.97	A	19,900	D
Common Stock^F1	Mar 22, 2018	S	19,900	$21.07	D	0	D
Common Stock	Mar 23, 2018	M	11,200	$11.97	A	11,200	D
Common Stock^F2	Mar 23, 2018	S	11,200	$20.52	D	0	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F3	$11.97	Mar 22, 2018	M	19,900	D	—	Jan 3, 2027	Common Stock	19,900	176,784	D
Stock Option (Right to Buy)^F3	$11.97	Mar 23, 2018	M	11,200	D	—	Jan 3, 2027	Common Stock	11,200	165,584	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.30, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $20.65, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. The option vests over four years, with 53,500 of the shares of common stock underlying the option vesting on 1/1/2018 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service.